Diana Shipping Accuses Genco of Maintaining Poison Pill
Diana Shipping (DSX), the largest shareholder of Genco Shipping & Trading (GNK), addressed a series of new conditions regarding Genco's poison pill that have been announced by the Genco Board of Directors. Diana urges shareholders not to be distracted by Genco's blatant attempt to confuse shareholders with empty promises. After Institutional Shareholder Services' recommendation that Genco shareholders vote AGAINST the ratification of Genco's poison pill, the Genco Board had an opportunity to demonstrate its supposed "commitment to strong corporate governance and shareholder engagement" and indicate that it would rescind the poison pill if shareholders vote against it. Instead, the Board chose to cling to the poison pill - the centerpiece of its entrenchment strategy - and reaffirm its commitment to maintaining the pill with a few self-serving, meaningless last minute qualifications. Genco shareholders should not be manipulated into accepting such a poison pill.
Trade with 70% Backtested Accuracy
Analyst Views on DSX
About DSX
About the author

- Increased Acquisition Offer: Diana Shipping has raised its offer to acquire Genco Shipping to an implied value of $27.34 per share, consisting of $24.80 in cash and one Diana share, reflecting the company's commitment to the acquisition.
- Significant Premium: The revised offer represents a 53% premium over Genco's closing price on November 21, 2025, and a 16% premium over its closing price of $23.51 on June 16, indicating Diana's confidence in Genco's market value.
- Financing Assurance: The cash component of the acquisition is fully financed with $1.433 billion in committed financing from six leading international banks, with no financing conditions, which enhances market trust in Diana Shipping's capability to complete the deal.
- Request to Delay Shareholder Meeting: Diana Shipping has urged Genco to postpone its Annual Meeting scheduled for June 18, allowing shareholders sufficient time to evaluate the increased offer, demonstrating Diana's commitment to shareholder interests.
- Increased Acquisition Offer: Diana Shipping has raised its offer for Genco Shipping to an implied value of $27.34 per share, comprising $24.80 in cash and one share of Diana, indicating a strategic move to attract shareholder support by recognizing Genco's asset value.
- Financing Assurance: The cash component of the offer is fully financed with $1.433 billion committed from six leading international banks, which mitigates transaction risks and enhances market confidence in the acquisition's viability.
- Request to Delay Shareholder Meeting: Diana has formally requested Genco to postpone its annual meeting scheduled for June 18, 2026, allowing the Genco Board and shareholders ample time to evaluate the revised offer, demonstrating Diana's commitment to a thorough assessment process.
- CEO Statement: Diana's CEO Semiramis Paliou noted that since November 2025, four increasingly compelling proposals have been submitted, with the latest offering significant premiums and immediate cash value for Genco shareholders, reflecting confidence in the combined entity's market potential.
- Increased Acquisition Offer: Diana has raised its offer for Genco to $27.34 per share, comprising $24.80 in cash and one share valued at $2.54, representing a 53% premium for Genco shareholders, indicating Diana's strong acquisition intent.
- Financing Assurance: The cash component of the acquisition is fully backed by $1.433 billion in committed financing from six international banks, ensuring the transaction's smooth execution and bolstering shareholder confidence.
- Request to Delay Shareholder Meeting: Diana has requested Genco to postpone its annual shareholder meeting scheduled for June 18, allowing the Genco Board and shareholders ample time to evaluate the enhanced acquisition proposal, demonstrating Diana's desire for deeper engagement with Genco.
- Market Consolidation Potential: The merger of Diana and Genco would create one of the largest dry bulk operators globally, enhancing market scale and flexibility, and is expected to narrow Diana's current trading discount, further increasing long-term shareholder value.
- Shareholder Voting Appeal: Genco Shipping & Trading is urging shareholders to vote in favor of the company's board nominees by June 17, 2026, emphasizing that this action is crucial for protecting shareholder interests.
- Opposition to Competitor Nominees: The company has explicitly opposed the nominees from Diana Shipping Inc., asserting that their proposals are not in the best interests of Genco shareholders, aiming to safeguard the existing governance structure.
- Advisory Firm Support: Genco noted that leading advisory firms ISS, Glass Lewis, and Egan-Jones have all backed the reelection of the board and recommended shareholders withhold votes on Diana's nominees, indicating strong market confidence in the current management.
- Slight Stock Price Increase: In pre-market trading on the NYSE, Genco shares rose by 0.33% to $24.14, reflecting a positive market response to the stability of the company's governance.
- Shareholder Voting Appeal: Diana Shipping Inc. is urging Genco shareholders to vote against the company's poison pill plan at the upcoming annual meeting, emphasizing the detrimental impact of this plan on shareholder interests, particularly given the board's failure to address shareholder concerns.
- Controversy Over Poison Pill: The Genco Board's insistence on maintaining the poison pill, despite ISS's recommendation for shareholders to vote against it, reflects a disregard for shareholder democracy, which could erode trust in the company's governance.
- Details of the Tender Offer: Diana has increased its cash tender offer from $23.50 to $24.80 per share, extending the deadline to June 26, 2026, aiming to attract Genco shareholders by providing a cash premium that enhances the appeal of its acquisition.
- Board Change Proposal: Diana has nominated Jens Ismar and Paul Cornell to the Genco Board, believing they can bring necessary fresh perspectives and independence to improve corporate governance and better serve shareholder interests.
- Shareholder Nomination: As the largest shareholder of Genco Shipping & Trading, Diana Shipping is urging investors to vote for its two board nominees, Jens Ismar and Paul Cornell, at the June 18 annual meeting, aiming to enhance shareholder value through new leadership.
- Opposition to Incentive Plan: Diana Shipping is also asking shareholders to reject Genco's proposed equity incentive plan and poison pill extension, with proxy advisor ISS recommending against both proposals due to excessive costs and a potential 3.8% share dilution.
- Executive Compensation Controversy: The company criticized Genco's board for increasing executive compensation despite reporting a net loss in 2025, accusing directors of prioritizing management interests over those of shareholders, highlighting governance issues.
- Ongoing Tender Offer: Diana Shipping's all-cash tender offer at $24.80 per share remains active until June 26, 2026, allowing shareholders to participate regardless of their votes at the annual meeting, further bolstering support for holding the board accountable.






